Autonomix Medical, Inc. (AMIX)
3.84
-0.18
(-4.48%)
USD |
NASDAQ |
Sep 28, 16:00
3.84
0.00 (0.00%)
After-Hours: 16:42
Autonomix Medical Research and Development Expense (TTM) : 7.066M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.066M |
| March 31, 2026 | 7.144M |
| December 31, 2025 | 7.237M |
| September 30, 2025 | 6.557M |
| June 30, 2025 | 5.364M |
| March 31, 2025 | 4.725M |
| Date | Value |
|---|---|
| December 31, 2024 | 4.013M |
| September 30, 2024 | 3.656M |
| June 30, 2024 | 2.897M |
| March 31, 2024 | 2.311M |
| December 31, 2023 | 1.789M |
| September 30, 2023 | 1.301M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Abbott Laboratories | 3.128B |
| AngioDynamics, Inc. | 29.45M |
| Alphatec Holdings, Inc. | 76.69M |
| AtriCure, Inc. | 94.05M |
| Baxter International, Inc. | 480.00M |